8-K//Current report
NGM BIOPHARMACEUTICALS INC 8-K
Accession 0001628280-24-010229
CIK 0001426332operating
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:13 PM ET
Size
298.0 KB
Accession
0001628280-24-010229
Documents
- 8-Kngm-20240311.htmPrimary
8-K
- EX-99.1ngm-20240311xexx99.htm
EX-99.1
- EX-101.SCHngm-20240311.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABngm-20240311_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREngm-20240311_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICngmlogoprimarycopy.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001628280-24-010229-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLngm-20240311_htm.xml
IDEA: XBRL DOCUMENT
Issuer
NGM BIOPHARMACEUTICALS INC
CIK 0001426332
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001426332
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 4:13 PM ET
- Size
- 298.0 KB